Recruiting NCT07059936
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Hepatocellular Carcinoma (HCC). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
CT imaging data and MR imaging data from liver cancer (hepatocellular carcinoma) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
Primary outcome measures
- disease-free survival [Time frame: 1 year]
- Progression-free survival [Time frame: 1 year]
- overall survival [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Patients were treated for hepatocellular carcinoma in Wuhan Union Hospital from July 2025 to July 2026;
- Aged > 18 years old;
- At least one CT scan or MR scan before treatment;
- Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion criteria
- Poor image quality;
- Incomplete clinical data or loss of follow-up;
- Presence of another primary malignancy other than liver cancer;
- Unclear pathological diagnosis.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
China · 1 center
- Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan
Identifiers
NCT: NCT07059936 · 2025-0620